Strategic Partnerships CEPI is a high-profile coalition that partners with public, private, philanthropic and civil organizations to accelerate vaccine development. This creates opportunities to position complementary services such as advanced analytics, supply chain optimization, regulatory support, and alliance-building services that streamline collaborative R&D efforts.

100 Days Mission The focus on delivering vaccines and countermeasures within 100 days signals a strong need for rapid development, testing, manufacturing readiness, and scalable deployment capabilities. Potential sales angles include rapid data management platforms, fast-tracking workflows, and emergency project management tools tailored for urgent vaccine programs.

Funding-backed Initiatives With CEPI actively pursuing multi-billion funding for its 2027–2031 strategy and government commitments such as a $50 million pledge, there is appetite for co-development, grant management support, and financial analytics solutions to monitor funding utilization, milestones, and impact reporting.

Recent Collaborations Recent partnerships with Moderna, DiosynVax, Pop Biotechnologies, SK Bioscience, and other biotech players indicate a broad vendor and partner network. This presents opportunities to offer collaboration-enabled platforms, IP management, secure data sharing, and vendor due diligence services aligned with multi-partner vaccine development programs.

Operational Scale With a sizable global footprint, ongoing external funding, and a substantial focus on diverse countermeasure platforms (mRNA, protein vaccines, nanoliposome platforms), CEPI represents demand for enterprise-grade data infrastructure, cybersecurity, cloud-based collaboration tools, and regulatory-compliant analytics to manage complex, multi-stakeholder programs.